Custom Search

News

Thursday 01 March 2001

Olanzapine: another psychotropic?

By: Davis MP, Dickerson ED.

Am J Hosp Palliat Care 2001 Mar-Apr;18(2):129-32

Olanzapine is a favorable drug with a potential treatment of delirium, psychotic depression, mood disorders and nausea with a single drug in advanced cancer patients. Additional benefits include weight gain. The medication has few drug interactions, a narrow therapeutic window and high drug cost, which is a disadvantage compounded by a single route of administration. Reduced hospitalizations, at least in the psychiatric patient, may offset the drug cost.

Use of this site is subject to the following terms of use